Yang S - Search Results

1

Orchestration of ErbB3 signaling through heterointeractions and homointeractions.

McCabe Pryor M, Steinkamp MP, Halasz AM, Chen Y, Yang S, Smith MS, Zahoransky-Kohalmi G, Swift M, Xu XP, Hanein D, Volkmann N, Lidke DS, Edwards JS, Wilson BS. McCabe Pryor M, et al. Among authors: yang s. Mol Biol Cell. 2015 Nov 5;26(22):4109-23. doi: 10.1091/mbc.E14-06-1114. Epub 2015 Sep 16. Mol Biol Cell. 2015. PMID: 26378253 Free PMC article.

2

Mapping ErbB receptors on breast cancer cell membranes during signal transduction.

Yang S, Raymond-Stintz MA, Ying W, Zhang J, Lidke DS, Steinberg SL, Williams L, Oliver JM, Wilson BS. Yang S, et al. J Cell Sci. 2007 Aug 15;120(Pt 16):2763-73. doi: 10.1242/jcs.007658. Epub 2007 Jul 24. J Cell Sci. 2007. PMID: 17652160

3

Spatio-temporal modeling of signaling protein recruitment to EGFR.

Hsieh MY, Yang S, Raymond-Stinz MA, Edwards JS, Wilson BS. Hsieh MY, et al. Among authors: yang s. BMC Syst Biol. 2010 May 6;4:57. doi: 10.1186/1752-0509-4-57. BMC Syst Biol. 2010. PMID: 20459599 Free PMC article.

4

erbB3 is an active tyrosine kinase capable of homo- and heterointeractions.

Steinkamp MP, Low-Nam ST, Yang S, Lidke KA, Lidke DS, Wilson BS. Steinkamp MP, et al. Among authors: yang s. Mol Cell Biol. 2014 Mar;34(6):965-77. doi: 10.1128/MCB.01605-13. Epub 2013 Dec 30. Mol Cell Biol. 2014. PMID: 24379439 Free PMC article.

5

Role of metadherin in estrogen-regulated gene expression.

Li Y, Gonzalez Bosquet J, Yang S, Thiel KW, Zhang Y, Liu H, Leslie KK, Meng X. Li Y, et al. Among authors: yang s. Int J Mol Med. 2017 Aug;40(2):303-310. doi: 10.3892/ijmm.2017.3020. Epub 2017 Jun 13. Int J Mol Med. 2017. PMID: 28627585 Free PMC article.

6

Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers.

Reyes HD, Thiel KW, Carlson MJ, Meng X, Yang S, Stephan JM, Leslie KK. Reyes HD, et al. Among authors: yang s. Mol Diagn Ther. 2014 Apr;18(2):137-51. doi: 10.1007/s40291-013-0070-3. Mol Diagn Ther. 2014. PMID: 24403167 Free PMC article. Review.

7

Essential Protein PHB2 and Its Regulatory Mechanisms in Cancer.

Qi A, Lamont L, Liu E, Murray SD, Meng X, Yang S. Qi A, et al. Among authors: yang s. Cells. 2023 Apr 21;12(8):1211. doi: 10.3390/cells12081211. Cells. 2023. PMID: 37190120 Free PMC article. Review.

8

SETDB1 in cancer: overexpression and its therapeutic implications.

Lazaro-Camp VJ, Salari K, Meng X, Yang S. Lazaro-Camp VJ, et al. Among authors: yang s. Am J Cancer Res. 2021 May 15;11(5):1803-1827. eCollection 2021. Am J Cancer Res. 2021. PMID: 34094655 Free PMC article. Review.

9

Recent Advances of WEE1 Inhibitors and Statins in Cancers With p53 Mutations.

Meng X, Gao JZ, Gomendoza SMT, Li JW, Yang S. Meng X, et al. Among authors: yang s. Front Med (Lausanne). 2021 Oct 4;8:737951. doi: 10.3389/fmed.2021.737951. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34671620 Free PMC article. Review.

10

SETDB1: A perspective into immune cell function and cancer immunotherapy.

Johnson E, Salari K, Yang S. Johnson E, et al. Among authors: yang s. Immunology. 2023 May;169(1):3-12. doi: 10.1111/imm.13619. Epub 2022 Dec 21. Immunology. 2023. PMID: 36524435 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49,960 results

Search Page